Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

The book is a comprehensive resource on hair disorders, but lacks information on some conditions.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

The genetic variant studied does not affect PCOS symptoms in Kashmiri women.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Proper nutrition can help manage PCOS symptoms and improve overall health.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Studying acne-related syndromes helps us understand acne causes and can lead to new treatments.

AGA patients have higher insulin resistance and serum progranulin levels, suggesting a link to metabolic issues.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Insulin might be involved in causing hair loss and acne.

PCOS is a complex condition linked to hormonal imbalance and insulin resistance, with weight loss being important for management.

Metformin helps with PCOS symptoms no matter the patient's initial insulin resistance or weight.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.